Role of the ouabain-like factor and Na-K pump in rat and human genetic hypertension

Clinical and Experimental Hypertension

Volumn 20, Issue 5-6, 1998, Pages 629-639

  Ferrandi, M ^a   Manunta, P ^b   Rivera, R ^b   Bianchi, G ^b   Ferrari, P ^a  

^a Prassis Sigma Tau Research Institute   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Hypertension; Kidney; Milan rat strain; Na K pump; Ouabain; Ouabain like factor

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DIGITALIS LIKE FACTOR; OUABAIN;

ANIMAL TISSUE; CELL MEMBRANE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; ION TRANSPORT; NONHUMAN; RADIOIMMUNOASSAY; RAT;

EID: 0031872223     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969809053241     Document Type: Conference Paper

References (42)

1. Ferrari P. and Bianchi G., Membrane ion transports in hypertension. Handbook of Hypertension: Pathophysiology of Hypertension, Birkenhager W.H., Reid J.L., Elsevier Science B.V., 1997; vol. 17: 935-974.
2. Haddy F.J., Overbeck H.W. The role of humoral agents in volume expanded hypertension. Life Sciences 1976;19:935-948
3. de Wardener H.E., Mac Gregor G.A. Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. Kidney Int. 1980, 18: 1-9.
4. Blaustein M. Sodium ions, calcium ions, blood pressure regulation and hypertension: a reassessment and a hypothesis. Am. J. Physiol. 1977, 1 (3): C165-C173.
5. Tymiak A.A., Norman J.A., Bolgar M., Di Donato G.C., Lee H., Parker W.L., Lo L.C., Berova N., Nakanishi K., Haber E., Haupert G.T. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci USA. 1993;90:8189-8193.
6. Zhao N., Lo L.C., Berova N., Nakanishi K., Tymiak A., Ludens J.H., Haupert G.T. Na-K ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis. Biochemistry. 1995;34:9893-9896.
7. Lewis L.K., Yandle T.G., Lewis J.G., Richards A.M., Pidgeon G.B., Kaaja R.J., Nicholls M.G. Ouabain Is not detectable in human plasma. Hypertension. 1994;24:549-555.
8. Gomez-Sanchez E.P., Foecking M.F., Sellers D., Blankenship M.S., Gomez-Sanchez C.E. Is the circulating ouabain-like compound ouabain? Am J Hypertens. 1994;7:647-650.
9. Kelly R.A., Smith T.W. Is ouabain the endogenous digitalis? Circulation. 1992;86(2): 694-697.
10. Nicholls M.G., Richards A.M., Lewis L.K., Yandle T.G. Ouabain: a new steroid hormone? The Lancet. 1995;346:1381-1382.
11. Hansen O. Do putative endogenous digitalis-tike factors have a physiological role? Hypertension. 1994;24(5):640-642.
12. Barber B.R., Ferrari P., Bianchi G. The Milan hypertensive strain: a description of the model. Handbook of Hypertension. Ganten D., de Jong W., eds. Amsterdam, Elsevier; 1994:316-345.
13. Ferrandi M., Minotti E., Salardi S., Florio M., Bianchi G., Ferrari P. Ouabainlike factor in Milan hypertensive rats. Am J Physiol. 1992;263:F739-F748.
14. Ferrandi M., Minotti E., Florio M., Bianchi G., Ferrari P. Age-dependency and dietary influence on the hypothalamic ouabain-like factor in Milan hypertensive rats. J Hypertens. 1995;13:1571-1574.
15. Bianchi G., Fox U., Di Francesco GF., Bardi U., Radice M. The hypertensive role of the kidney in spontaneous hypertensive rats. Clin. Sci. Mol. Med. 1973, 45:135s-139s
16. Bianchi G., Fox U., Di Francesco G.F., Giovanetti A.M., Pagetti D. Blood pressure changes produced by kidney crosstransplantation between spontaneously hypertensive rats and normotensive rats. Clin. Sci. Mol. Med. 1974;47:435-448.
17. Ferrari P., Cusi D., Barber B.R., Barlassina C., Vezzoli G., Duzzi L., Minotti E., Bianchi G. Erythrocyte membrane and renal function in relation to hypertension in rats of the Milan hypertensive strain. Clin. Sci. 1982;63:61s-64s.
18. Bianchi G., Baer P.G., Fox U., Duzzi L., Pagetti D., Giovanetti AM. Changes in renin, water balance and sodium balance during development of high blood pressure in genetically hypertensive rats. Circ. Res. 1975, 36-37 (suppl. 1): I-153-I-161
19. Boberg U., Persson E.G., Increased tubuloglomerular feedback activity in Milan hypertensive rats. Am. J. Physiol. 1986, 250: F967-F974.
20. + transport across renal brush border membrane vesicles from rats of the Milan hypertensive strain. Biochim. Biophys. Acta 1985, 819:179-186.
21. + fluxes in membrane vesicles from kidneys of hypertensive and normotensive rats. Biochim. Biophys. Acta 1990, 1021:13-20.
22. Melzi M.L., Bertorello A., Fukuda Y., Muldin I., Serent F., Aperia A. Na,K-ATPase activity in renal tubule cells from Milan hypertensive rats. Am. J Hypertens. 1989;2:563-566.
23. Parenti P., Villa M., Hanozet G.M., Ferrandi M., Ferrari P. Increased Na pump activity in the kidney cortex of the Milan hypertensive rat strain. FEBS Lett. 1991;290:200-204.
24. Ferrandi M., Tripodi G., Salardi S., Florio M., Modica R., Barassi P., Parenti P., Shainskaya A., Karlish S., Bianchi G., Ferrari P. Renal Na-K ATPase in genetic hypertension. Hypertension 1996, 28:1018-1025.
25. Foulkes R., Ferrario R., Salvati P., Bianchi G. Differences in ouabain-induced natriuresis between isolated kidneys of Milan hypertensive and normotensive rats. Clin. Sci. 1992, 82:185-190.
26. Bianchi G., Ferrari P. A genetic approach to the pathogenesis of primary hypertension and to its treatment. Clin. Experim. Pharmacol. Physiol. 1995 (S2): S399-S405.
27. Guidi E., Menghetti D., Milani Pharm S., Montagnino G., Palazzt P., Bianchi G. Hypertension may be transplanted with the kidney in humans. J. Am. Soc. Nephrology 1996, in press
28. Bianchi G., Cusi D., Gatti M., Lupi G.P., Ferrari P., Barlassina C., Picotti G.B., Bracchi G., Colombo G., Gori D., Velis O., Mazzei D. A renal abnormality as a possible cause of "essential" hypertension. Lancet I: 173-177, 1979
29. Bianchi G., Cusi D., Barlassina C., Lupi G.P., Ferrari P., Picotti G.B., Gatti M., Polli E. Renal dysfunction as a possible cause of essential hypertension in predisposed subjects. Kidney Intern. 23:870-875, 1983
30. Bianchi G., Tripodi G., Casari G., Salardi S., Barber BR., Garcia R., Leoni P., Torielli L., Cusi D., Ferrandi M., Pinna LA., Baralle FE., Ferrari P. Two point mutations within the adducin gene are involved in blood pressure variation. Proc. Natl. Acad. Sci. USA 1994, 91:3999-4003.
31. Casari G., Barlassina C., Cusi D., Zagato L., Muirhead R., Righetti M., Nembri P., Amar K., Gatti M., macciardi F., Binelli G., Bianchi G. Association of the α-adducin tocus with essential hypertension. Hypertension 1995, 25: 320-326.
32. Cusi D., Barlassina C., Azzani T., Casari G., Citterio L., Devoto M., Glorioso N., Lanzant C., Manunta P., Righetti M., Rivera R., Stella P., Troffa C., Zagato L., Bianchi G. Polymorphisms of α-adducin and salt sensitivity in patients with essential hypertension. Lancet, 1997; 349: 1353-1357.
33. Hughes CA., Bennett V. Adducin: a physical model with implications for function in assembly of spectrin-actin complexes. J Biol. Chem. 1995, 270:18990-18996.
34. Tripodi G., Valtorta F., Torieili L., Chieregatti E., Salardi S., Trusolino L., Menegon A., Ferrari P., Marchisio PC., Bianchi G. Hypertension-associated point mutations in the adducin α and β subunits affect actin cytoskeleton and ion transport. J Clin. Invest. 1996, 97:2815-2822.
35. Manunta P., Rogowski A.C., Hamilton B.P., Hamlyn J.M. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens. 1994;12:549-560.
36. Ferrandi M., Manunta P., Balzan S., Hamlyn J., Bianchi G., Ferrari P. Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays. Hypertension 1997, in press.
37. Harris D.W., Clark M.A., Fisher J.F., Hamlyn J.M., Kolbasa K.P., Ludens J.H., Du Charme D.W. Development of an immunoassay for endogenous digitalis-like factor. Hypertension. 1991;17:936-943.
38. Tamura M., Harris TM., Phyllis D., Blair I.A., Wang Y., Hellerquist C.G. Identification of two cardiac glycosides as Na-pump inhibitors in rat urine and diet. J Biol. Chem. 1994,269:11972-11979.
39. Rossi G.P., Manunta P., Hamlyn J.M., Pavan E., De Toni R., Semplicini A., Pessina A.C. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. J Hypertens. 1995;13:1181-1191.
40. Manunta P., Rogowski A.C., Hamilton B.P., Hamlyn J.M. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens. 1994;12:549-560.
41. Quadri L., Bianchi G., Cerri A., Fedrizzi G., Ferrari P., Gobbini M., Melloni P., Sputore S., Torri M. 17 β-(3-Furyl)-5β-androstane-3β-14β-17α-triol (PST 2238): a very potent antihypertensive agent with a novel mechanism of action. J Med. Chem. 1997; 40: 1561-1564.
42. Ferrari P., Torielli L., Ferrandi M., Conti F., Duzzi L., Minotti E., Bianchi G. PST 2238, the new antagonist of the long-term ouabain pressor effect lowers blood pressure by modulating the Na-K ATPase at cell level. (Abs) J Hypertension 1997, 15 (suppl. 4), P2.35.